Phase 3 study comparing Yesintek with Stelara in adult patients with chronic plaque psoriasis shows positive results: Biocon Biologics Ruchika Sharma8 March 2025 1:30 PM ISTBengaluru: BioconBiologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd. has announced the successful results...
Biocon Biologics, Civica join hands to expand Insulin Aspart access in US Ruchika Sharma7 March 2025 11:30 AM ISTCivica will commercialize the medicine for patients in the United States, after completion of development work and clinical trials.
Biocon Biologics unveils Yesintek biosimilar to Stelara in US Ruchika Sharma25 Feb 2025 12:31 PM ISTYESINTEK will be available in all the same formulations currently provided by Stelara.
Biocon Biologics Yesintek gets European Commission approval for plaque psoriasis, psoriatic arthritis Ruchika Sharma18 Feb 2025 3:42 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the European...
Biocon Biologics Malaysia site classified as VAI by USFDA Ruchika Sharma13 Jan 2025 11:30 AM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (FDA) has classified Biocon Biologics' Insulins facilities in...
Biocon Biologics to present at 43rd Annual JP Morgan Healthcare Conference Ruchika Sharma10 Jan 2025 1:30 PM ISTKarnataka: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, will present at the 43rd Annual J.P....
Biocon Biologics gets Japenese nod for Psoriasis Vulgaris injection Ustekinumab BS Ruchika Sharma7 Jan 2025 1:15 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the...
Approval of Biocon Biologics Yesintek recommended by EMA Committee Ruchika Sharma16 Dec 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the European...
Biocon Biologics recognized as Asia IP Elite for 2024 by IAM Ruchika Sharma12 Dec 2024 12:39 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Limited, has announced that it has once again been recognized as an Asia IP Elite for...
Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel Farhat Nasim4 Dec 2024 5:00 PM ISTNew Delhi: Over the last five years, six pharmaceutical suppliers have been blacklisted for providing substandard medicines to Jan Aushadhi Kendras...
USFDA approves Biocon Biologics Yesintek for Crohn's disease, Ulcerative Colitis, Plaque Psoriasis, Psoriatic Arthritis Ruchika Sharma2 Dec 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced that the U.S. Food ...
Biocon Biologics Bengaluru drug substance facility classified as VAI Ruchika Sharma4 Nov 2024 12:30 PM ISTBengaluru: Biocon has announced that the U.S. Food and Drug Administration (USFDA) has classified Biocon Biologics' Drug Substance Facility at Biocon...
